Des Plaines Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in Des Plaines
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
Des Plaines News
Trio of Indian innovators join Sci-Tech Daresbury through Soft Landing Programme
TIBS Global, VenPep Solutions, and Everleaves Systems represent cutting-edge advancements across industrial IoT, automation, software and app development, AI and embedded engineering, and their ...
Senior journalists receive training on tech revolution in China
BEIJING: SENIOR journalists and government officials from Tanzania, South Sudan, Zimbabwe, Ivory Coast and Turkey are participating in an ongoing training seminar focused on leveraging the ...
Science, Technology and Society program hosts health care and civil liberties lecture
Doctors, administrators and patients faces challenges in putting the Affordable Care Act’s protections into practice inside hospitals.
SHELTON, CONNECTICUT / ACCESS Newswire / September 9, 2025 / NanoViricides, Inc. (NYSE American:NNVC ) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

